PHILADELPHIA -- Chyke Doubeni has been named the second Presidential Term Professor at the University of Pennsylvania. Doubeni, an expert on colorectal cancer and racial disparities in health care, is Presidential Term Associate Professor-Clinician Educator in the Department of Family Medicine and Community Health of Penn’s Perelman School of Medicine.
Faculty & Staff
PHILADELPHIA — We couldn’t live without our immune systems, always tuned to detect and eradicate invading pathogens and particles. But sometimes the immune response goes overboard, triggering autoimmune diseases like lupus, asthma or inflammatory bowel disease.
A new study led by University of Pennsylvania researchers has now identified a crucial signaling molecule involved in counterbalancing the immune system attack.
Michelle Denburg of the Perelman School of Medicine is highlighted for a grant to support research about patients with nephrotic syndrome and vitamin D deficiency.
Penn Public Safety to Conduct UPenn Alert Drill, Host Campus Fire Safety and Emergency Preparedness Day
Mark Devlin of the School of Arts and Sciences is featured for his healthy and active lifestyle outside of the classroom.
PHILADELPHIA — It’s not every day that a new academic discipline is born. But that’s exactly what happened in 2010, when the Project on Bioethics, Sexuality and Gender Identity — or “Queer Bioethics,” for short — came to life at the University of Pennsylvania.
What a difference a year makes.
PHILADELPHIA — Dogs with hemangiosarcoma that were treated with a compound derived from the Coriolus versicolor mushroom had the longest survival times ever reported for dogs with the disease. These promising findings offer hope that the compound may one day offer cancer patients — human and canine alike — a viable alternative or complementary treatment to traditional chemotherapies.
PHILADELPHIA — How does one’s experience of an event get translated into a memory that can be accessed months, even years later? A team led by University of Pennsylvania scientists has come closer to answering that question, identifying key molecules that help convert short-term memories into long-term ones. These proteins may offer a target for drugs that can enhance memory, alleviating some of the cognitive symptoms that characterize conditions including schizophrenia, depression and Parkinson’s and Alzheimer’s diseases.